Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations?
Amets Sáenz(Instituto de Salud Carlos III), Adolfo López de Munaín(Universidad de Deusto), Lorea Blázquez, Juan José Poza(Biomedical Research Networking Center on Neurodegenerative Diseases), Miguel Urtasun(Instituto de Salud Carlos III), Hiroyuki Sorimachi(Japan Science and Technology Agency), Alberto Marina(Centro de Investigación Biomédica en Red), María Goicoechea(Instituto de Salud Carlos III), France Leturcq(Centre National de la Recherche Scientifique), F. García-Bragado(Hospital Virgen del Camino), Naoko Doi(Tokushima Municipal Hospital), Margarita Azpitarte(Biogipuzkoa Health Research Institute), Jean‐Claude Kaplan(Centre National de la Recherche Scientifique), Yasuko Ono(Tokyo Metropolitan Institute of Medical Science)
Cited by 13
Related Papers
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies
|British Journal Of Nutrition|2014|448
Structure, Activation, and Biology of Calpain
|Diabetes|2004|412
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
|Nature Medicine|2011|333
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
|Nature Communications|2016|210